Stockscreener 앱 받기
2.47
3.78%
0.09
시간 외 거래:
2.46
-0.01
-0.40%
전일 마감가:
$2.38
열려 있는:
$2.33
하루 거래량:
1.50M
Relative Volume:
0.30
시가총액:
$236.37M
수익:
-
순이익/손실:
$-84.23M
주가수익비율:
-2.674
EPS:
-0.9237
순현금흐름:
$-77.15M
1주 성능:
-18.21%
1개월 성능:
-24.70%
6개월 성능:
-67.92%
1년 성능:
-25.83%
1일 변동 폭
$2.29
$2.495
1주일 범위
$2.29
$3.10
52주 변동 폭
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
명칭
Rezolute Inc
전화
650-206-4507
주소
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
2.47 | 227.76M | 0 | -84.23M | -77.15M | -0.9237 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-11-05 | 개시 | Wedbush | Outperform |
| 2024-08-27 | 개시 | Guggenheim | Buy |
| 2024-07-17 | 개시 | BTIG Research | Buy |
| 2024-06-04 | 개시 | Craig Hallum | Buy |
| 2024-04-09 | 개시 | Maxim Group | Buy |
| 2022-08-02 | 재개 | Canaccord Genuity | Buy |
| 2022-06-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-09-08 | 개시 | ROTH Capital | Buy |
| 2021-05-27 | 개시 | Oppenheimer | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
모두보기
Rezolute Inc 주식(RZLT)의 최신 뉴스
Forecast Cut: Will Rezolute Inc outperform during market ralliesEntry Point & Growth Oriented Trade Recommendations - baoquankhu1.vn
Can Rezolute Inc sustain earnings growthWeekly Investment Recap & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout - MSN
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - GlobeNewswire Inc.
Rezolute (RZLT) price target decreased by 61.18% to 6.25 - MSN
RZLT Investor Sentiment - Investing.com Canada
Rezolute Shares Reeling After Clinical Trial Setback - StocksToTrade
22NW LP Invests $7.71 Million in Rezolute, Inc. $RZLT - MarketBeat
Mangrove Partners IM LLC Increases Stake in Rezolute, Inc. - National Today
Mangrove Partners IM LLC Acquires 584,660 Shares of Rezolute, Inc. $RZLT - MarketBeat
Integral Health Asset Management Boosts Stake in Rezolute, Inc. - National Today
RZLT Stock Price, Quote & Chart | REZOLUTE INC (NASDAQ:RZLT) - ChartMill
Analyst Upgrade: Is Rezolute Inc stock trending bullish2026 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn
RZLT.O Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Macro: Is Rezolute Inc a top pick in the sector2025 Short Interest & Daily Momentum Trading Reports - baoquankhu1.vn
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute - bastillepost.com
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT) - Sahm
Rezolute to Participate in the Citizens Life Sciences Conference - The Manila Times
RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Nasdaq
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire
Legal Scrutiny Follows Rezolute's Clinical Trial Setback - AD HOC NEWS
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Bluefield Daily Telegraph
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
RZLT.O Should I Buy - Intellectia AI
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Craig-Hallum Remains a Hold on Rezolute (RZLT) - The Globe and Mail
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Q1 Earnings Estimate for Rezolute Issued By HC Wainwright - MarketBeat
Will Rezolute Inc. benefit from rate cutsEarnings Summary Report & Consistent Profit Focused Trading Strategies - mfd.ru
RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
How Rezolute Inc. stock reacts to global recession fearsJuly 2025 Price Swings & Stepwise Swing Trade Plans - mfd.ru
Oculis and Rezolute Contrast Financial Strength - National Today
Biotech Company Advances Breakthrough Hyperinsulinism Treatment - streetwisereports.com
Rezolute Reports Q2 Loss, Downgrades Ahead - Intellectia AI
MSN Money - MSN
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Beh - GuruFocus
Is Rezolute Inc. a top pick in the sectorWeekly Investment Recap & High Return Stock Watch Alerts - mfd.ru
Is Rezolute Inc. benefiting from interest rate changesWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru
Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results - MarketBeat
Rezolute (RZLT) Reports Decline in Cash Reserves by Year-End - GuruFocus
Phase 3 miss hits Rezolute (NASDAQ: RZLT) as losses widen and cash burn rises - Stock Titan
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - The Manila Times
Press Release: Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - 富途牛牛
Is Rezolute Inc. backed by strong institutional buyingTrade Exit Report & Short-Term Swing Trade Alerts - mfd.ru
Can Rezolute Inc. navigate macro headwindsInflation Watch & Proven Capital Preservation Tips - mfd.ru
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire
Rezolute Inc (RZLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rezolute Inc 주식 (RZLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Dec 16 '25 |
Buy |
1.70 |
28,000 |
47,600 |
308,352 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.77 |
40,000 |
70,640 |
415,900 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.79 |
5,000 |
8,938 |
7,000 |
| Elam Nevan C | CEO |
Dec 15 '25 |
Buy |
1.59 |
32,000 |
50,880 |
641,119 |
| Karnawat Sunil Ratilal | Chief Commercial Officer |
Dec 15 '25 |
Buy |
1.62 |
12,100 |
19,599 |
71,542 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 25 '25 |
Buy |
4.38 |
2,500 |
10,939 |
15,500 |
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
1.20%
0.06%
자본화:
|
볼륨(24시간):